These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 27182682)
1. Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model. Wang S; Ouyang B; Aa J; Geng J; Fei F; Wang P; Wang J; Peng Y; Geng T; Li Y; Huang W; Wang Z; Xiao W; Wang G J Pharm Biomed Anal; 2016 Jul; 126():109-16. PubMed ID: 27182682 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the prototype and hydrolyzed carboxylic forms of ginkgolides A, B, and K administered as a ginkgo diterpene lactones meglumine injection in beagle dogs. Wang SY; A JY; Fei F; Geng JL; Peng Y; Ouyang BC; Wang P; Jin XL; Zhao YQ; Wang JK; Geng T; Li YJ; Huang WZ; Wang ZZ; Xiao W; Wang GJ Chin J Nat Med; 2017 Oct; 15(10):775-784. PubMed ID: 29103463 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies of ginkgolide K in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography-tandem mass spectrometry. Fan ZY; Liu XG; Guo RZ; Dong X; Gao W; Li P; Yang H J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():1-7. PubMed ID: 25734938 [TBL] [Abstract][Full Text] [Related]
4. Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract. Huang P; Zhang L; Chai C; Qian XC; Li W; Li JS; Di LQ; Cai BC J Pharm Biomed Anal; 2014 Nov; 100():138-144. PubMed ID: 25165009 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the ginkgo B following intravenous administration of ginkgo B emulsion in rats. Chen WD; Liang Y; Xie L; Lu T; Liu XD; Wang GJ Biol Pharm Bull; 2007 Jan; 30(1):1-5. PubMed ID: 17202649 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics study of ginkgolide A, B and the effect of food on bioavailability after oral administration of ginkgolide extracts in beagle dogs. Aa L; Fei F; Tan Z; Aa J; Wang G; Liu C Biomed Chromatogr; 2018 Jun; 32(6):e4212. PubMed ID: 29516538 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ginkgolide B injection in beagle dogs. Song H; Bu F; Wei C; Yuan G; Liu X; Wang B; Guo R Arzneimittelforschung; 2012 Dec; 62(12):595-8. PubMed ID: 23093483 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans. Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430 [TBL] [Abstract][Full Text] [Related]
9. [Study on the pharmacokinetics of ginkgolide B for injection in rats]. Zhang XT; Jiao HY; Suo QL Zhong Yao Cai; 2012 Mar; 35(3):430-3. PubMed ID: 22876684 [TBL] [Abstract][Full Text] [Related]
10. Validated LC-MS-MS method for the determination of prodrug of ginkgolide B in rat plasma and brain: application to pharmacokinetic study. Yuan Y; Pan J; Wu Z; Hui A; Zhou A J Chromatogr Sci; 2013 Mar; 51(3):266-72. PubMed ID: 22933510 [TBL] [Abstract][Full Text] [Related]
11. [Absolute bioavailability of ginkgolide compounds in rats]. Si HH; Geng T; Sun XP; Zhao J; Xue J Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(14):2882-6. PubMed ID: 26666044 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs. Zhao J; Geng T; Wang Q; Si H; Sun X; Guo Q; Li Y; Huang W; Ding G; Xiao W Molecules; 2015 Nov; 20(11):20031-41. PubMed ID: 26561795 [TBL] [Abstract][Full Text] [Related]
13. [Study on pharmacokinetics of ginkgolide B injection in Beagle dogs]. Zhang XT; Jiao HY; Suo QL Zhong Yao Cai; 2012 May; 35(5):762-5. PubMed ID: 23213741 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution study of ginkgolide L in rats by ultra-high performance liquid chromatography coupled with tandem mass spectrometry. Wang JX; Liu XG; Fan ZY; Dong X; Lou FC; Li P; Yang H J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Dec; 1006():30-36. PubMed ID: 26519619 [TBL] [Abstract][Full Text] [Related]
15. Characterizations of the hydrolyzed products of ginkgolide A and ginkgolide B by liquid chromatography coupled with mass spectrometry. Lan K; Li XJ; Du G; Xu L J Pharm Biomed Anal; 2016 Jan; 118():113-122. PubMed ID: 26540626 [TBL] [Abstract][Full Text] [Related]
16. Determination of Ginkgolides A, B, C, J and Bilobalide in Plasma by LC-ESI (-)/MS/MS (QQQ) and its Application to the Pharmacokinetic Study of Ginkgo Biloba Extract in Rats. Yan-Yan Z; Li-Li G; Guo-Ming S; Rong R; Jing-Zhen T Drug Res (Stuttg); 2016 Oct; 66(10):520-526. PubMed ID: 27490936 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and conversion of the lactone to the carboxylate forms of ginkgolide B in rat plasma. Wang DL; Peng DY; Tao XH; Cao Y; Chen WD; Liang Y; Xie L; Liu XD J Asian Nat Prod Res; 2013; 15(4):337-43. PubMed ID: 23421864 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS. Biber A; Koch E Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)]. Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A Therapie; 1995; 50(2):137-44. PubMed ID: 7631288 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, in silico and in vivo blood brain barrier permeability of ginkgolide B cinnamate. Lu YM; Pan J; Zhang WN; Hui AL; Guo WQ; Huang L; Zhu QJ; Chen Y Fitoterapia; 2015 Oct; 106():110-4. PubMed ID: 26327588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]